Humoral and cellular immune response to Sars-CoV-2 wild-type and variants of concern following 3-dose vaccination in a large cohort of adults with cancer: The SerOzNET study.Eva Segelov, Elizabeth Ahern, Amy Body et al.|Journal of Clinical Oncology|2022Cited by 0
Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstractEva Segelov, Elizabeth Ahern, Amy Body et al.|Cancer Research|2022Cited by 0
Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNETEva Segelov, Elizabeth Ahern, Robert McCuaig et al.|Cancer Research|2022Cited by 0